(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 5.55%1.37B | -24.05%5.43B | -24.69%4.06B | -27.96%2.71B | -31.90%1.3B | 12.44%7.15B | 16.49%5.4B | 20.74%3.76B | 50.67%1.91B | 19.64%6.36B |
Operating income | 5.55%1.37B | -24.05%5.43B | -24.69%4.06B | -27.96%2.71B | -31.90%1.3B | 12.44%7.15B | 16.49%5.4B | 20.74%3.76B | 50.67%1.91B | 19.64%6.36B |
Cost of sales | ---- | 7.63%-4.49B | ---- | 31.15%-1.75B | ---- | -11.33%-4.86B | ---- | -18.91%-2.54B | ---- | -32.36%-4.37B |
Operating expenses | -6.21%-899.55M | 7.63%-4.49B | 25.55%-2.72B | 31.15%-1.75B | 36.37%-846.99M | -11.33%-4.86B | -15.11%-3.65B | -18.91%-2.54B | -56.63%-1.33B | -32.36%-4.37B |
Gross profit | 4.33%473.7M | -58.92%940.9M | -22.87%1.34B | -21.30%958.96M | -21.61%454.03M | 14.88%2.29B | 19.50%1.74B | 24.73%1.22B | 38.56%579.16M | -1.15%1.99B |
Selling expenses | 45.34%-92.31M | 0.21%-517.42M | -9.16%-402.92M | -27.48%-310.49M | -40.39%-168.88M | -20.44%-518.5M | -25.52%-369.12M | -24.87%-243.56M | -35.67%-120.29M | -5.28%-430.49M |
Administrative expenses | 19.87%-89.6M | 9.15%-674.55M | 5.06%-306.24M | -8.13%-322.3M | -15.44%-111.82M | -11.09%-742.46M | -14.19%-322.56M | -14.95%-298.08M | -5.11%-96.86M | -11.75%-668.33M |
Research and development expenses | -33.11%-35.29M | ---- | 8.63%-152.22M | ---- | -26.96%-26.51M | ---- | -52.92%-166.59M | ---- | -17.38%-20.88M | ---- |
Profit from asset sales | -71.48%28.61K | ---- | -170.69%-549.39K | ---- | 73.94%100.32K | ---- | -59.70%777.18K | ---- | --57.67K | ---- |
Revaluation surplus | 161.07%27.62M | ---- | 351.88%37.14M | ---- | -82.62%10.58M | ---- | -114.20%-14.75M | ---- | 599.70%60.88M | ---- |
-Changes in the fair value of other assets | 161.07%27.62M | ---- | 351.88%37.14M | ---- | -82.62%10.58M | ---- | -114.20%-14.75M | ---- | 599.70%60.88M | ---- |
Impairment and provision | 296.86%38.78M | -137.48%-145.02M | 111.37%2.45M | 54.37%-4.22M | 188.75%9.77M | 81.21%-61.07M | -46.66%-21.59M | 13.05%-9.25M | -368.74%-11.01M | -2,039.33%-325.05M |
-Impairment of property, machinery and equipment | ---- | ---44.52M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Goodwill impairment | ---- | ---68.16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairment is provision | 296.86%38.78M | 47.03%-32.35M | 111.37%2.45M | 54.37%-4.22M | 188.75%9.77M | 81.21%-61.07M | -46.66%-21.59M | 13.05%-9.25M | -368.74%-11.01M | -2,039.33%-325.05M |
Operating interest expense | ---- | 7.14%-228.09M | ---- | -2.61%-126.23M | ---- | -16.92%-245.63M | ---- | -13.51%-123.01M | ---- | 19.46%-210.07M |
Special items of operating profit | -587.74%-58.38M | -30.13%143.79M | -417.16%-254.45M | 46.49%204.3M | 56.94%-8.49M | 1,300.25%205.78M | -200.51%-49.2M | 7,643.53%139.46M | -152.99%-19.71M | -104.72%-17.15M |
Operating profit | 68.26%259.58M | -151.75%-480.38M | -67.91%252.97M | -41.52%400.01M | -58.15%154.28M | 171.05%928.31M | -0.32%788.4M | 68.76%684.03M | 41.72%368.63M | -68.77%342.49M |
Financing cost | 22.20%-62.73M | ---- | -238.56%-74.15M | ---- | 5.30%-80.63M | ---- | 123.17%53.52M | ---- | -9.35%-85.14M | ---- |
Share of profits of associates | ---- | -354.95%-447.95M | ---- | -322.41%-232.29M | ---- | 18.11%-98.46M | ---- | -679.76%-54.99M | ---- | -152.05%-120.23M |
Special items of earning before tax | -500.17%-15.64M | ---- | 387.62%2.36M | ---- | 564.75%3.91M | ---- | 87.12%-818.96K | ---- | -394.24%-841.05K | ---- |
Earning before tax | 133.64%181.21M | -211.87%-928.33M | -78.46%181.17M | -73.34%167.73M | -72.56%77.56M | 273.36%829.85M | 51.91%841.1M | 51.64%629.04M | 55.23%282.65M | -83.26%222.26M |
Tax | -129.20%-26.61M | 209.89%126.18M | 79.43%-39.29M | 61.76%-45.36M | 75.51%-11.61M | -1,132.52%-114.82M | -97.75%-191.03M | -51.47%-118.64M | -20.30%-47.41M | 103.63%11.12M |
After-tax profit from continuing operations | 134.42%154.6M | -212.18%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.38%715.04M | 42.23%650.06M | 51.68%510.4M | 64.87%235.24M | -77.16%233.38M |
Earning after tax | 134.42%154.6M | -212.18%-802.16M | -78.17%141.89M | -76.03%122.37M | -71.97%65.95M | 206.38%715.04M | 42.23%650.06M | 51.68%510.4M | 64.87%235.24M | -77.16%233.38M |
Minority profit | 25.19%-442.43K | -52.55%-18.9M | 41.45%-1.28M | -33.56%-983K | -299.90%-591.38K | -67.34%-12.39M | 50.61%-2.19M | 55.74%-736K | 136.73%295.84K | -187.20%-7.4M |
Profit attributable to shareholders | 133.00%155.04M | -207.68%-783.26M | -78.05%143.17M | -75.87%123.35M | -71.68%66.54M | 202.10%727.43M | 41.33%652.26M | 51.15%511.14M | 63.74%234.94M | -76.49%240.79M |
Basic earnings per share | 133.33%0.1057 | -206.00%-0.53 | -78.04%0.0976 | -77.14%0.08 | -71.71%0.0453 | 212.50%0.5 | 41.34%0.4445 | 52.17%0.35 | 63.70%0.1601 | -78.95%0.16 |
Diluted earnings per share | 133.33%0.1057 | -206.00%-0.53 | -78.04%0.0976 | -77.14%0.08 | -71.71%0.0453 | 212.50%0.5 | 41.34%0.4445 | 52.17%0.35 | 63.70%0.1601 | -78.95%0.16 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young (Special General Partnership) | -- | -- | -- | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data